Global Rabies Vaccine Market Insights and Forecast to 2027

Publisher Name :
Date: 11-May-2021
No. of pages: 115
Inquire Before Buying

Rabies Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rabies Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

- Vero Cell Rabies Vaccine

- BHK

- Chick Embryo Cell Rabies Vaccine

- Others

Segment by Application

- Pre-exposure Prophylaxis

- Post-exposure Prophylaxis

By Company

- GSK (Novartis)

- Sanofi-Pasteur

- Chengda

- Yisheng

- Prcmise

- VACN

- Changsheng

- BCHT

- Hissen

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

Global Rabies Vaccine Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Rabies Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Rabies Vaccine Market Size Growth Rate by Type
1.4.2 Vero Cell Rabies Vaccine
1.4.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rabies Vaccine Market Size Growth Rate by Application
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rabies Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global Rabies Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global Rabies Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Rabies Vaccine Regions by Sales
2.4.1 Global Top Rabies Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top Rabies Vaccine Regions by Sales (2022-2027)
2.5 Global Top Rabies Vaccine Regions by Revenue
2.5.1 Global Top Rabies Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top Rabies Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Rabies Vaccine Sales by Manufacturers
3.1.1 Global Top Rabies Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Rabies Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Rabies Vaccine Sales in 2020
3.2 Global Rabies Vaccine Revenue by Manufacturers
3.2.1 Global Top Rabies Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Rabies Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Rabies Vaccine Revenue in 2020
3.3 Global Rabies Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Rabies Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rabies Vaccine Sales by Type
4.1.1 Global Rabies Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global Rabies Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global Rabies Vaccine Sales Market Share by Type (2016-2027)
4.2 Global Rabies Vaccine Revenue by Type
4.2.1 Global Rabies Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global Rabies Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Rabies Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global Rabies Vaccine Price by Type
4.3.1 Global Rabies Vaccine Price by Type (2016-2021)
4.3.2 Global Rabies Vaccine Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Rabies Vaccine Sales by Application
5.1.1 Global Rabies Vaccine Historical Sales by Application (2016-2021)
5.1.2 Global Rabies Vaccine Forecasted Sales by Application (2022-2027)
5.1.3 Global Rabies Vaccine Sales Market Share by Application (2016-2027)
5.2 Global Rabies Vaccine Revenue by Application
5.2.1 Global Rabies Vaccine Historical Revenue by Application (2016-2021)
5.2.2 Global Rabies Vaccine Forecasted Revenue by Application (2022-2027)
5.2.3 Global Rabies Vaccine Revenue Market Share by Application (2016-2027)
5.3 Global Rabies Vaccine Price by Application
5.3.1 Global Rabies Vaccine Price by Application (2016-2021)
5.3.2 Global Rabies Vaccine Price Forecast by Application (2022-2027)
6 North America
6.1 North America Rabies Vaccine Market Size by Type
6.1.1 North America Rabies Vaccine Sales by Type (2016-2027)
6.1.2 North America Rabies Vaccine Revenue by Type (2016-2027)
6.2 North America Rabies Vaccine Market Size by Application
6.2.1 North America Rabies Vaccine Sales by Application (2016-2027)
6.2.2 North America Rabies Vaccine Revenue by Application (2016-2027)
6.3 North America Rabies Vaccine Market Size by Country
6.3.1 North America Rabies Vaccine Sales by Country (2016-2027)
6.3.2 North America Rabies Vaccine Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Rabies Vaccine Market Size by Type
7.1.1 Europe Rabies Vaccine Sales by Type (2017-2027)
7.1.2 Europe Rabies Vaccine Revenue by Type (2017-2027)
7.2 Europe Rabies Vaccine Market Size by Application
7.2.1 Europe Rabies Vaccine Sales by Application (2017-2027)
7.2.2 Europe Rabies Vaccine Revenue by Application (2017-2027)
7.3 Europe Rabies Vaccine Market Size by Country
7.3.1 Europe Rabies Vaccine Sales by Country (2017-2027)
7.3.2 Europe Rabies Vaccine Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rabies Vaccine Market Size by Type
8.1.1 Asia Pacific Rabies Vaccine Sales by Type (2018-2027)
8.1.2 Asia Pacific Rabies Vaccine Revenue by Type (2018-2027)
8.2 Asia Pacific Rabies Vaccine Market Size by Application
8.2.1 Asia Pacific Rabies Vaccine Sales by Application (2018-2027)
8.2.2 Asia Pacific Rabies Vaccine Revenue by Application (2018-2027)
8.3 Asia Pacific Rabies Vaccine Market Size by Region
8.3.1 Asia Pacific Rabies Vaccine Sales by Region (2018-2027)
8.3.2 Asia Pacific Rabies Vaccine Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Rabies Vaccine Market Size by Type
9.1.1 Latin America Rabies Vaccine Sales by Type (2019-2027)
9.1.2 Latin America Rabies Vaccine Revenue by Type (2019-2027)
9.2 Latin America Rabies Vaccine Market Size by Application
9.2.1 Latin America Rabies Vaccine Sales by Application (2019-2027)
9.2.2 Latin America Rabies Vaccine Revenue by Application (2019-2027)
9.3 Latin America Rabies Vaccine Market Size by Country
9.3.1 Latin America Rabies Vaccine Sales by Country (2019-2027)
9.3.2 Latin America Rabies Vaccine Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Rabies Vaccine Market Size by Type
6.1.1 Middle East and Africa Rabies Vaccine Sales by Type (2016-2027)
6.1.2 Middle East and Africa Rabies Vaccine Revenue by Type (2016-2027)
6.2 Middle East and Africa Rabies Vaccine Market Size by Application
6.2.1 Middle East and Africa Rabies Vaccine Sales by Application (2016-2027)
6.2.2 Middle East and Africa Rabies Vaccine Revenue by Application (2016-2027)
6.3 Middle East and Africa Rabies Vaccine Market Size by Country
6.3.1 Middle East and Africa Rabies Vaccine Sales by Country (2016-2027)
6.3.2 Middle East and Africa Rabies Vaccine Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 GSK (Novartis)
11.1.1 GSK (Novartis) Corporation Information
11.1.2 GSK (Novartis) Overview
11.1.3 GSK (Novartis) Rabies Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GSK (Novartis) Rabies Vaccine Product Description
11.1.5 GSK (Novartis) Related Developments
11.2 Sanofi-Pasteur
11.2.1 Sanofi-Pasteur Corporation Information
11.2.2 Sanofi-Pasteur Overview
11.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Sanofi-Pasteur Rabies Vaccine Product Description
11.2.5 Sanofi-Pasteur Related Developments
11.3 Chengda
11.3.1 Chengda Corporation Information
11.3.2 Chengda Overview
11.3.3 Chengda Rabies Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Chengda Rabies Vaccine Product Description
11.3.5 Chengda Related Developments
11.4 Yisheng
11.4.1 Yisheng Corporation Information
11.4.2 Yisheng Overview
11.4.3 Yisheng Rabies Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Yisheng Rabies Vaccine Product Description
11.4.5 Yisheng Related Developments
11.5 Prcmise
11.5.1 Prcmise Corporation Information
11.5.2 Prcmise Overview
11.5.3 Prcmise Rabies Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Prcmise Rabies Vaccine Product Description
11.5.5 Prcmise Related Developments
11.6 VACN
11.6.1 VACN Corporation Information
11.6.2 VACN Overview
11.6.3 VACN Rabies Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 VACN Rabies Vaccine Product Description
11.6.5 VACN Related Developments
11.7 Changsheng
11.7.1 Changsheng Corporation Information
11.7.2 Changsheng Overview
11.7.3 Changsheng Rabies Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Changsheng Rabies Vaccine Product Description
11.7.5 Changsheng Related Developments
11.8 BCHT
11.8.1 BCHT Corporation Information
11.8.2 BCHT Overview
11.8.3 BCHT Rabies Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 BCHT Rabies Vaccine Product Description
11.8.5 BCHT Related Developments
11.9 Hissen
11.9.1 Hissen Corporation Information
11.9.2 Hissen Overview
11.9.3 Hissen Rabies Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Hissen Rabies Vaccine Product Description
11.9.5 Hissen Related Developments
11.1 GSK (Novartis)
11.1.1 GSK (Novartis) Corporation Information
11.1.2 GSK (Novartis) Overview
11.1.3 GSK (Novartis) Rabies Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 GSK (Novartis) Rabies Vaccine Product Description
11.1.5 GSK (Novartis) Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Rabies Vaccine Value Chain Analysis
12.2 Rabies Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rabies Vaccine Production Mode & Process
12.4 Rabies Vaccine Sales and Marketing
12.4.1 Rabies Vaccine Sales Channels
12.4.2 Rabies Vaccine Distributors
12.5 Rabies Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Rabies Vaccine Industry Trends
13.2 Rabies Vaccine Market Drivers
13.3 Rabies Vaccine Market Challenges
13.4 Rabies Vaccine Market Restraints
14 Key Findings in The Global Rabies Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Rabies Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Vero Cell Rabies Vaccine
Table 3. Major Manufacturers of BHK
Table 4. Major Manufacturers of Chick Embryo Cell Rabies Vaccine
Table 5. Major Manufacturers of Others
Table 6. Global Rabies Vaccine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Rabies Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Rabies Vaccine Sales by Region (2016-2021) & (K Units)
Table 9. Global Rabies Vaccine Sales Market Share by Region (2016-2021)
Table 10. Global Rabies Vaccine Sales by Region (2016-2021) & (K Units)
Table 11. Global Rabies Vaccine Sales Market Share by Region (2022-2027)
Table 12. Global Rabies Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Rabies Vaccine Revenue Market Share by Region (2016-2021)
Table 14. Global Rabies Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Rabies Vaccine Revenue Market Share by Region (2022-2027)
Table 16. Global Rabies Vaccine Sales by Manufacturers (2016-2021) & (K Units)
Table 17. Global Rabies Vaccine Sales Share by Manufacturers (2016-2021)
Table 18. Global Rabies Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Rabies Vaccine Revenue Share by Manufacturers (2016-2021)
Table 20. Rabies Vaccine Price by Manufacturers 2016-2021 (USD/Unit)
Table 21. Global Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2020)
Table 23. Rabies Vaccine Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Rabies Vaccine Product Offered
Table 25. Date of Manufacturers Enter into Rabies Vaccine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 28. Global Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 29. Global Rabies Vaccine Sales Share by Type (2016-2021)
Table 30. Global Rabies Vaccine Sales Share by Type (2022-2027)
Table 31. Global Rabies Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Rabies Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Rabies Vaccine Revenue Share by Type (2016-2021)
Table 34. Global Rabies Vaccine Revenue Share by Type (2022-2027)
Table 35. Rabies Vaccine Price by Type (2016-2021) & (USD/Unit)
Table 36. Global Rabies Vaccine Price Forecast by Type (2022-2027) & (USD/Unit)
Table 37. Global Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 38. Global Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 39. Global Rabies Vaccine Sales Share by Application (2016-2021)
Table 40. Global Rabies Vaccine Sales Share by Application (2022-2027)
Table 41. Global Rabies Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Rabies Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Rabies Vaccine Revenue Share by Application (2016-2021)
Table 44. Global Rabies Vaccine Revenue Share by Application (2022-2027)
Table 45. Rabies Vaccine Price by Application (2016-2021) & (USD/Unit)
Table 46. Global Rabies Vaccine Price Forecast by Application (2022-2027) & (USD/Unit)
Table 47. North America Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 48. North America Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 49. North America Rabies Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Rabies Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 52. North America Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 53. North America Rabies Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Rabies Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 56. North America Rabies Vaccine Sales by Country (2022-2027) & (K Units)
Table 57. North America Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 60. Europe Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 61. Europe Rabies Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Rabies Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 64. Europe Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 65. Europe Rabies Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Rabies Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 68. Europe Rabies Vaccine Sales by Country (2022-2027) & (K Units)
Table 69. Europe Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 72. Asia Pacific Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 73. Asia Pacific Rabies Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Rabies Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 76. Asia Pacific Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 77. Asia Pacific Rabies Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Rabies Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Rabies Vaccine Sales by Region (2016-2021) & (K Units)
Table 80. Asia Pacific Rabies Vaccine Sales by Region (2022-2027) & (K Units)
Table 81. Asia Pacific Rabies Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Rabies Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 84. Latin America Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 85. Latin America Rabies Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Rabies Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 88. Latin America Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 89. Latin America Rabies Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Rabies Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 92. Latin America Rabies Vaccine Sales by Country (2022-2027) & (K Units)
Table 93. Latin America Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Rabies Vaccine Sales by Type (2016-2021) & (K Units)
Table 96. Middle East and Africa Rabies Vaccine Sales by Type (2022-2027) & (K Units)
Table 97. Middle East and Africa Rabies Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Rabies Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Rabies Vaccine Sales by Application (2016-2021) & (K Units)
Table 100. Middle East and Africa Rabies Vaccine Sales by Application (2022-2027) & (K Units)
Table 101. Middle East and Africa Rabies Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Rabies Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Rabies Vaccine Sales by Country (2016-2021) & (K Units)
Table 104. Middle East and Africa Rabies Vaccine Sales by Country (2022-2027) & (K Units)
Table 105. Middle East and Africa Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 107. GSK (Novartis) Corporation Information
Table 108. GSK (Novartis) Description and Major Businesses
Table 109. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. GSK (Novartis) Rabies Vaccine Product
Table 111. GSK (Novartis) Recent Developments
Table 112. Sanofi-Pasteur Corporation Information
Table 113. Sanofi-Pasteur Description and Major Businesses
Table 114. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Sanofi-Pasteur Rabies Vaccine Product
Table 116. Sanofi-Pasteur Recent Developments
Table 117. Chengda Corporation Information
Table 118. Chengda Description and Major Businesses
Table 119. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Chengda Rabies Vaccine Product
Table 121. Chengda Recent Developments
Table 122. Yisheng Corporation Information
Table 123. Yisheng Description and Major Businesses
Table 124. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Yisheng Rabies Vaccine Product
Table 126. Yisheng Recent Developments
Table 127. Prcmise Corporation Information
Table 128. Prcmise Description and Major Businesses
Table 129. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Prcmise Rabies Vaccine Product
Table 131. Prcmise Recent Developments
Table 132. VACN Corporation Information
Table 133. VACN Description and Major Businesses
Table 134. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. VACN Rabies Vaccine Product
Table 136. VACN Recent Developments
Table 137. Changsheng Corporation Information
Table 138. Changsheng Description and Major Businesses
Table 139. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Changsheng Rabies Vaccine Product
Table 141. Changsheng Recent Developments
Table 142. BCHT Corporation Information
Table 143. BCHT Description and Major Businesses
Table 144. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. BCHT Rabies Vaccine Product
Table 146. BCHT Recent Developments
Table 147. Hissen Corporation Information
Table 148. Hissen Description and Major Businesses
Table 149. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Hissen Rabies Vaccine Product
Table 151. Hissen Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Rabies Vaccine Distributors List
Table 155. Rabies Vaccine Customers List
Table 156. Rabies Vaccine Market Trends
Table 157. Rabies Vaccine Market Drivers
Table 158. Rabies Vaccine Market Challenges
Table 159. Rabies Vaccine Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Vaccine Product Picture
Figure 2. Global Rabies Vaccine Market Share by Type in 2020 & 2027
Figure 3. Vero Cell Rabies Vaccine Product Picture
Figure 4. BHK Product Picture
Figure 5. Chick Embryo Cell Rabies Vaccine Product Picture
Figure 6. Others Product Picture
Figure 7. Global Rabies Vaccine Sales Market Share by Application in 2020 & 2027
Figure 8. Pre-exposure Prophylaxis
Figure 9. Post-exposure Prophylaxis
Figure 10. Rabies Vaccine Report Years Considered
Figure 11. Global Rabies Vaccine Sales 2016-2027 (K Units)
Figure 12. Global Rabies Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Rabies Vaccine Revenue 2016-2027 (US$ Million)
Figure 14. Global Rabies Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Rabies Vaccine Sales Market Share by Region (2016-2021)
Figure 16. Global Rabies Vaccine Sales Market Share by Region (2022-2027)
Figure 17. North America Rabies Vaccine Sales YoY (2016-2027) & (K Units)
Figure 18. North America Rabies Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Rabies Vaccine Sales YoY (2016-2027) & (K Units)
Figure 20. Europe Rabies Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Rabies Vaccine Sales YoY (2016-2027) & (K Units)
Figure 22. Asia-Pacific Rabies Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Rabies Vaccine Sales YoY (2016-2027) & (K Units)
Figure 24. Latin America Rabies Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Rabies Vaccine Sales YoY (2016-2027) & (K Units)
Figure 26. Middle East & Africa Rabies Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Rabies Vaccine Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Rabies Vaccine Revenue in 2020
Figure 29. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Rabies Vaccine Sales Market Share by Type (2016-2027)
Figure 31. Global Rabies Vaccine Revenue Market Share by Type (2016-2027)
Figure 32. Global Rabies Vaccine Sales Market Share by Application (2016-2027)
Figure 33. Global Rabies Vaccine Revenue Market Share by Application (2016-2027)
Figure 34. North America Rabies Vaccine Sales Market Share by Type (2016-2027)
Figure 35. North America Rabies Vaccine Revenue Market Share by Type (2016-2027)
Figure 36. North America Rabies Vaccine Sales Market Share by Application (2016-2027)
Figure 37. North America Rabies Vaccine Revenue Market Share by Application (2016-2027)
Figure 38. North America Rabies Vaccine Sales Share by Country (2016-2027)
Figure 39. North America Rabies Vaccine Revenue Share by Country (2016-2027)
Figure 40. U.S. Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Rabies Vaccine Sales Market Share by Type (2016-2027)
Figure 43. Europe Rabies Vaccine Revenue Market Share by Type (2016-2027)
Figure 44. Europe Rabies Vaccine Sales Market Share by Application (2016-2027)
Figure 45. Europe Rabies Vaccine Revenue Market Share by Application (2016-2027)
Figure 46. Europe Rabies Vaccine Sales Share by Country (2016-2027)
Figure 47. Europe Rabies Vaccine Revenue Share by Country (2016-2027)
Figure 48. Germany Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 49. France Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Rabies Vaccine Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Rabies Vaccine Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Rabies Vaccine Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Rabies Vaccine Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Rabies Vaccine Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Rabies Vaccine Revenue Share by Region (2016-2027)
Figure 59. China Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 62. India Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 64. Taiwan Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 68. Philippines Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 69. Latin America Rabies Vaccine Sales Market Share by Type (2016-2027)
Figure 70. Latin America Rabies Vaccine Revenue Market Share by Type (2016-2027)
Figure 71. Latin America Rabies Vaccine Sales Market Share by Application (2016-2027)
Figure 72. Latin America Rabies Vaccine Revenue Market Share by Application (2016-2027)
Figure 73. Latin America Rabies Vaccine Sales Share by Country (2016-2027)
Figure 74. Latin America Rabies Vaccine Revenue Share by Country (2016-2027)
Figure 75. Mexico Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 76. Brazil Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 77. Argentina Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 78. Middle East and Africa Rabies Vaccine Sales Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Rabies Vaccine Revenue Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Rabies Vaccine Sales Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Rabies Vaccine Revenue Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Rabies Vaccine Sales Share by Country (2016-2027)
Figure 83. Middle East and Africa Rabies Vaccine Revenue Share by Country (2016-2027)
Figure 84. Turkey Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 85. Saudi Arabia Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 86. U.A.E Rabies Vaccine Revenue (2016-2027) & (US$ Million)
Figure 87. Rabies Vaccine Value Chain
Figure 88. Rabies Vaccine Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
  • Cystic Fibrosis - Pipeline Insight, 2021
    Published: 29-Jul-2021        Price: US 0 Onwards        Pages: 60
    DelveInsight's, "Cystic Fibrosis - Pipeline Insight, 2021," report provides comprehensive insights about 60+ companies and 60+ pipeline drugs in Cystic Fibrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered - Global cov......
  • Global Indocyanine Green (CAS 3599-32-4) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 29-Jul-2021        Price: US 5900 Onwards        Pages: 115
    Indocyanine green (ICG) a cyanine dye used in medical diagnostics to determine cardiac output, hepatic function, and liver blood flow, and for ophthalmic angiography. It is a sterile, lyophilized green powder with a peak spectral absorption at 800 nm. These infrared frequencies penetrate retinal layers, allowing ICG angiography to image deeper patterns of circulation than fluorescein angiography. Europe is the largest Indocyanine Green (CAS 3599-32-4) market with about 52% market share. U......
  • Global Antacid Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 29-Jul-2021        Price: US 5900 Onwards        Pages: 125
    Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach ......
  • Global Codeine Phosphate Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 29-Jul-2021        Price: US 5900 Onwards        Pages: 139
    Codeine phosphate is a type of medicine called an opioid. Codeine is a mild painkiller, but also has cough suppressant and anti-diarrhoeal actions. Global Codeine Phosphate key players include Macfarian Smith, Francopia, Noramco, etc. Global top three manufacturers hold a share over 40%. Europe is the largest market, with a share about 30%, followed by East & South Asia, and North America, both have a share over 35 percent. In terms of product, Extracted from Opium is the lar......
  • Global Opioid-Induced Constipation Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 28-Jul-2021        Price: US 5900 Onwards        Pages: 122
    Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives. Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share about 55%, followed by Europe, and ......
  • Global Human Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 28-Jul-2021        Price: US 5900 Onwards        Pages: 147
    A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%. East China is the largest market, with a share about 25%, fol......
  • Global Colistin Sulphate Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 27-Jul-2021        Price: US 5900 Onwards        Pages: 115
    Colistin, also known as polymyxin E, is an antibiotic produced by certain strains of the bacteria Paenibacillus polymyxa. Colistin is a mixture of the cyclic polypeptides colistin A and B and belongs to the class of polypeptide antibiotics known as polymyxins. Colistin is effective against most Gram-negative bacilli. Colistin is composed of Polymyxins E1 and E2 (or Colistins A, B, and C). Colistin is the least toxic member of the group. Colistin is used as a sulfate or as sulfomethy......
  • 2021-2027 Global and Regional Budesonide Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 27-Jul-2021        Price: US 3500 Onwards        Pages: 131
    The global Budesonide market was valued at 7254.49 Million USD in 2020 and will grow with a CAGR of 3.26% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, Sout......
  • Global Alpha-2 Antiplasmin Sales Market Report 2021
    Published: 26-Jul-2021        Price: US 4000 Onwards        Pages: 145
    The global Alpha-2 Antiplasmin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alpha-2 Antiplasmin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - by Forms - - Plasminogen Binding......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs